2020 American Transplant Congress
Dual Donor-Recipient Intervention with Recombinant Human C1 Inhibitor Prevents Delayed Graft Function and Reduces Antibody-Mediated Rejection after Kidney Transplantation in Non-Human Primates
*Purpose: Patients with delayed graft function (DGF) are at increased risk for rejection and inferior graft survival. Complement activation during brain death and ischemia reperfusion…2020 American Transplant Congress
Comparative Study between ATG and Grafalon as Induction Agent in Renal Transplant Recipient
Kidney and Liver Transplant, Shahid Dharmabhakta National Transplant Center, Kathmandu, Nepal
*Purpose: Renal transplantation (Rtx) remains the most effective treatment for of end-stage renal disease (ESRD). The development of induction therapy has significantly reduced the incidence…2020 American Transplant Congress
Single-Cell RNA Sequencing Reveals Gene Expression Profiling of Ischemia Reperfusion Injury
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
*Purpose: Ischemia-reperfusion injury (IRI) during liver transplantation is an important factor that leads to graft dysfunction and even recipient death. This study aims to explore…2020 American Transplant Congress
Health Professional Level Barriers to Living Donor Kidney Transplantation: A Mixed Methods Study
1McGill University, Montreal, QC, Canada, 2University of Montreal, Montreal, QC, Canada
*Purpose: Despite the benefits of living donor kidney transplantation (LDKT), rates have stagnated. Efforts to increase LDKT have focused on patient level barriers. Health professionals…2020 American Transplant Congress
Outcomes of High KDPI Kidneys in Selected Recipients at a Large Center
Miami Transplant Institute, Miami, FL
*Purpose: Kidneys from donors with high KDPI’s are frequently discarded due to concerns about short- and long-term outcomes. Despite the decreased graft survival of these…2020 American Transplant Congress
Significance of Pathology in Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients on 1 Year Outcomes: Interim Results of the Paramour “Pediatric Renal AMR Outcomes” Study
*Purpose: Little is known about how pathology findings on biopsy correlate with outcomes in pediatric kidney transplant patients with antibody mediated rejection (AMR). We aimed…2020 American Transplant Congress
Can a Patient with Von Willebrand Disease Donate a Kidney?
*Purpose: Von Willebrand disease (VWD) is a haematological condition that can be challenging to deal with during any operative intervention. We report a successful example…2020 American Transplant Congress
Systemic Venous versus Portal Venous Drainage in Simultaneous Pancreas-Kidney Transplantation: A Matched-Pair Analysis
Abdominal Transplant Surgery, Wake Forest Baptist Health, Winston Salem, NC
*Purpose: The study purpose was to evaluate outcomes in vascularized pancreas transplantation (PTx) with enteric exocrine drainage based on technique of venous delivery.*Methods: We retrospectively…2020 American Transplant Congress
Renoportal Vein Graft for Complete Portal Vein Thrombosis: A Reproducible Technique for a Challenging Problem
Baylor University Medical Center, Dallas, TX
*Purpose: Type-IV Yerdel portal vein thrombosis (PVT) was historically contraindicated in liver transplant due to lack of appropriate portal vein inflow. Renoportal vein graft (RPVG)…2020 American Transplant Congress
Single versus Dual Immunosuppression in Liver Transplantation for Autoimmune Liver Diseases
*Purpose: There is limited evidence on the optimal maintenance immunosuppression after liver transplant (LT) for primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and autoimmune…
- « Previous Page
- 1
- …
- 169
- 170
- 171
- 172
- 173
- …
- 223
- Next Page »